Cargando…

Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study

Long‐standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry, including increased cortical bone thickness (CBT). However, a high prevalence and incidence of vertebral fractures has been reported. The aim of this study was to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Godang, Kristin, Lekva, Tove, Normann, Kjersti Ringvoll, Olarescu, Nicoleta Cristina, Øystese, Kristin Astrid Berland, Kolnes, Anders, Ueland, Thor, Bollerslev, Jens, Heck, Ansgar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894724/
https://www.ncbi.nlm.nih.gov/pubmed/31844828
http://dx.doi.org/10.1002/jbm4.10240
_version_ 1783476439720394752
author Godang, Kristin
Lekva, Tove
Normann, Kjersti Ringvoll
Olarescu, Nicoleta Cristina
Øystese, Kristin Astrid Berland
Kolnes, Anders
Ueland, Thor
Bollerslev, Jens
Heck, Ansgar
author_facet Godang, Kristin
Lekva, Tove
Normann, Kjersti Ringvoll
Olarescu, Nicoleta Cristina
Øystese, Kristin Astrid Berland
Kolnes, Anders
Ueland, Thor
Bollerslev, Jens
Heck, Ansgar
author_sort Godang, Kristin
collection PubMed
description Long‐standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry, including increased cortical bone thickness (CBT). However, a high prevalence and incidence of vertebral fractures has been reported. The aim of this study was to assess the course of cortical bone dimensions in the hip by comparing patients with acromegaly and clinically nonfunctioning pituitary adenomas (NFPAs) at baseline and 1 year after pituitary surgery (1‐year PO) in a longitudinal cohort study. DXA was performed in patients with acromegaly (n = 56) and NFPA (n = 47). CBT in the femoral neck (CBTneck), calcar (CBTcalcar), and shaft (CBTshaft) were determined by hip structural analysis (HSA). CBT at baseline and the change to 1‐year PO were compared. Test results were adjusted for differences in gender distribution, age, and gonadal status. Cortical thickness analyses showed higher values [mm] at baseline in patients with acromegaly compared with NFPA: CBTneck median [25th; 75th] 6.2 [4.7; 8.0] versus 5.1 [4.1; 6.4] (p = 0.006), CBTcalcar 4.8 [4.2, 5.7] versus 4.0 [3.2, 4.5] (p < 0.001), CBTshaft 6.2 [5.1, 7.2] versus 5.2 [4.6, 6.0], (p = 0.003). In acromegaly, GH was correlated with CBTneck (r = 0.31, p = 0.020), whereas IGF‐1 was correlated with CBTcalcar (r = 0.39, p = 0.003) at baseline. In acromegaly, CBTneck decreased by 11.2%, p = 0.002 during follow‐up. Finally, the decrease in CBTneck and CBTcalcar in acromegaly was significant compared with NFPA (p = 0.023 and p = 0.017, respectively). Previous observations of increased CBT in acromegaly were confirmed with DXA‐derived HSA in a large, well‐defined cohort. The decline in CBT in acromegaly could contribute to the increased fracture risk in acromegaly despite increased bone dimensions and disease control. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-6894724
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-68947242019-12-16 Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study Godang, Kristin Lekva, Tove Normann, Kjersti Ringvoll Olarescu, Nicoleta Cristina Øystese, Kristin Astrid Berland Kolnes, Anders Ueland, Thor Bollerslev, Jens Heck, Ansgar JBMR Plus Original Articles Long‐standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry, including increased cortical bone thickness (CBT). However, a high prevalence and incidence of vertebral fractures has been reported. The aim of this study was to assess the course of cortical bone dimensions in the hip by comparing patients with acromegaly and clinically nonfunctioning pituitary adenomas (NFPAs) at baseline and 1 year after pituitary surgery (1‐year PO) in a longitudinal cohort study. DXA was performed in patients with acromegaly (n = 56) and NFPA (n = 47). CBT in the femoral neck (CBTneck), calcar (CBTcalcar), and shaft (CBTshaft) were determined by hip structural analysis (HSA). CBT at baseline and the change to 1‐year PO were compared. Test results were adjusted for differences in gender distribution, age, and gonadal status. Cortical thickness analyses showed higher values [mm] at baseline in patients with acromegaly compared with NFPA: CBTneck median [25th; 75th] 6.2 [4.7; 8.0] versus 5.1 [4.1; 6.4] (p = 0.006), CBTcalcar 4.8 [4.2, 5.7] versus 4.0 [3.2, 4.5] (p < 0.001), CBTshaft 6.2 [5.1, 7.2] versus 5.2 [4.6, 6.0], (p = 0.003). In acromegaly, GH was correlated with CBTneck (r = 0.31, p = 0.020), whereas IGF‐1 was correlated with CBTcalcar (r = 0.39, p = 0.003) at baseline. In acromegaly, CBTneck decreased by 11.2%, p = 0.002 during follow‐up. Finally, the decrease in CBTneck and CBTcalcar in acromegaly was significant compared with NFPA (p = 0.023 and p = 0.017, respectively). Previous observations of increased CBT in acromegaly were confirmed with DXA‐derived HSA in a large, well‐defined cohort. The decline in CBT in acromegaly could contribute to the increased fracture risk in acromegaly despite increased bone dimensions and disease control. © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2019-10-23 /pmc/articles/PMC6894724/ /pubmed/31844828 http://dx.doi.org/10.1002/jbm4.10240 Text en © 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Godang, Kristin
Lekva, Tove
Normann, Kjersti Ringvoll
Olarescu, Nicoleta Cristina
Øystese, Kristin Astrid Berland
Kolnes, Anders
Ueland, Thor
Bollerslev, Jens
Heck, Ansgar
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title_full Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title_fullStr Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title_full_unstemmed Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title_short Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study
title_sort hip structure analyses in acromegaly: decrease of cortical bone thickness after treatment: a longitudinal cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894724/
https://www.ncbi.nlm.nih.gov/pubmed/31844828
http://dx.doi.org/10.1002/jbm4.10240
work_keys_str_mv AT godangkristin hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT lekvatove hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT normannkjerstiringvoll hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT olarescunicoletacristina hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT øystesekristinastridberland hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT kolnesanders hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT uelandthor hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT bollerslevjens hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy
AT heckansgar hipstructureanalysesinacromegalydecreaseofcorticalbonethicknessaftertreatmentalongitudinalcohortstudy